Atrial Arrhythmias in Patients with Severe COVID-19
Table 5
Arrhythmias, cardiomyocyte injury markers, and death between <65-year-old and ≥65-year-old patients with COVID-19.
Variable
<65-year-old (N = 48)
≥65-year-old (N = 36)
value
Male/female (n)
25/23
19/17
0.95
Age (years)
52.30 ± 9.10
74.60 ± 7.20
<0.01
Total heart rate (beats/24 hrs)
6146624.13 (3979387.20, 9102121.30)
3788754.79 (2126971.80, 7602033.70)
0.94
Maximum heart rate (bpm)
133.70 ± 15.90
123.90 ± 26.60
0.12
Minimum heart rate (bpm)
59.20 ± 8.10
56.10 ± 13.00
0.39
Mean heart rate (bpm)
83.00 ± 8.80
80.60 ± 12.80
0.59
PAC (beats/24 hrs)
210.80 (30.30, 1131.50)
1717.50 (207.70, 52761.20)
0.12
NSAT (n/24 hrs)
0 (0, 20.00)
42.7 (0, 800.10)
0.21
AF (n)
1 (2.10)
3(8.30)
0.31
PVC (beats/24 hrs)
48 (0, 555.10)
1195.50 (45.30, 5012.50)
0.71
NSVT (n/24 hrs)
0 (0, 0)
0 (0, 0)
0.42
AVB (n/24 hrs)
0
3 (8.30)
0.08
CKMB (ng/mL)
0.90 (0.60, 1.40)
1.50 (0.90, 3.60)
<0.01
hscTnI (ng/mL)
0.01(0.01, 0.01)
0.01 (0.01, 0.02)
<0.01
Myoglobin (ng/mL)
5.00 (3.40, 12.20)
8.3 (6.80, 53.10)
0.11
Death (n)
2 (4.20)
5 (13.90)
0.13
Data are expressed as mean (SD) or median (IQR) for continuous variables and number (%) for categorical variables. AF, atrial fibrillation; AVB, atrioventricular block; CKMB, creatine kinase isoenzyme; COVID-19, novel coronavirus disease 2019; hscTnI, high-sensitive cardiac troponin I; PAC, premature atrial contracts; PVC, premature ventricular contracts; NSAT, nonsustained atrial tachycardia; NSVT, nonsustained ventricular tachycardia.
